Immunoadsorption to remove 2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME
Considerations for Long-Term Users If you plan to use BPC-157 beyond a standard 46 week cycle, consider: Taking extended breaks between cycles Using the lowest effective dose Rotating injection sites to avoid local tissue fatigue or inflammation Monitoring subjective markers of progress and potential side effects (energy, GI symptoms, inflammation, blood pressure) Until clinical data becomes available, long-term safety remains uncertain so the guiding principle should be minimal effective use for specific, time-bound recovery goals
Thompson DR (2001) Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis
Another study showed that neonatal exposure to BPA induced metaplasia, hyperplasia and inflammation, altering prostate morphogenesis and increasing the susceptibility to develop precancerous prostatic lesions, with the development of PCa in adult and elderly life [304,305,306]
J Mol Neurosci 18:7-14